ARCHIVES

MET Inhibitor Improved Time To Progression by 56 Percent

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

ONS Opposes AMA On “Registered Care Technologist”

August 19, 1988

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013

FDA Policy: silicone Breast Implant Restrictions Stand, FDA Tells Petitioners

November 7, 1997

New ACS Program Honors Mary Lasker

August 31, 1984

NCI To Proceed With Guidelines Unless Board Strongly Disagree

May 9, 1980

Eight Scientists Receive $800,000 From Milken

January 12, 1990